Toussaint, Clara
Bézard, Erwan
Lemoine, Maël
Planche, Vincent
Article History
Received: 8 July 2025
Accepted: 11 October 2025
First Online: 11 November 2025
Declarations
:
: Not applicable.
: E.B. is a director and shareholder of Motac Neuroscience Ltd. During the past 3 years, V.P. was a local unpaid investigator or sub-investigator for clinical trials granted by Novo Nordisk, Biogen, Janssen, and Alector. V.P. served as a consultant for Motac Neuroscience Ltd, outside the submitted work. Other authors declare no competing interests.